Good question. his resume is pretty good.
he specialises in CR's for medical companies and has experience in getting at least 2 medical companies to takeover bids. he was also the sales VP for a company that was purchased by Boston for $26billion where his portfolio was responsible for at least a $1billion of yearly revenue. so, I say they is necessary
Ann: Annual Report to shareholders, page-3
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.11 |
Change
-0.110(0.54%) |
Mkt cap ! $388.8M | |||
| Open | High | Low | Value | Volume |
| $20.20 | $20.50 | $20.11 | $23.02K | 1.132K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 113 | $20.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.50 | 1951 | 1 |
View Market Depth
| Last trade - 12.23pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.17 |
Change
-0.110 ( 0.64 %) |
||||
| Open | High | Low | Volume | ||
| $20.17 | $20.17 | $20.17 | 64 | ||
| Last updated 11.49am 16/05/2024 ? | |||||
| AVR (ASX) Chart |